TheraCryf (LSE:TCF) Total Payout Yield %: -111.52 (As of Jul. 11, 2026)


What is TheraCryf Total Payout Yield %?

TheraCryf LSE:TCF Total Payout Yield % is -111.52 as of Jul. 11, 2026. The stock has 3 warning signs investors should review.

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

TheraCryf's current Total Payout Yield % is -111.52%.

TheraCryf Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.

TheraCryf Total Payout Yield % Related Terms

TheraCryf Total Payout Yield % Historical Data

* Premium members only.

The historical data trend for TheraCryf's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf Total Payout Yield % Chart

TheraCryf Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Payout Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -54.25 0.00 0.00 0.00 -107.52

TheraCryf Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -56.22 -177.43 0.00

LSE:TCF vs VRTX, REGN, ALNY: Total Payout Yield % Comparison

For the Biotechnology subindustry, TheraCryf's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TheraCryf Total Payout Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where TheraCryf's Total Payout Yield % falls into.


TheraCryf Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

TheraCryf's Total Payout Yield % for the fiscal year that ended in Mar. 2025 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 5.152 + 0) / 4.7916495
=-107.52%

TheraCryf's annualized Total Payout Yield % for the quarter that ended in Sep. 2025 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 2 / 4.6202726
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Yield % →
What does a Total Payout Yield % of -111.52 mean?
TheraCryf (LSE:TCF) has a Total Payout Yield % of -111.52 as of Jul. 11, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on TheraCryf and its competitors.
Is TheraCryf's Total Payout Yield % too high?
TheraCryf's current Total Payout Yield % is -111.52.
How does TheraCryf's Total Payout Yield % compare to VRTX and REGN?
TheraCryf's Total Payout Yield % of -111.52 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Biotechnology company?
A good Total Payout Yield % depends on the Biotechnology industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on TheraCryf and its competitors. TheraCryf's current Total Payout Yield % is -111.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TheraCryf stock overvalued right now?
TheraCryf (LSE:TCF) has a current Total Payout Yield % of -111.52. The current Total Payout Yield % is -111.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current Total Payout Yield % is -111.52 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.